Add Yahoo as a preferred source to see more of our stories on Google. New research suggests a pill may soon replace CPAPs as the treatment of choice for sleep apnea. A new drug could put an end to ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

There is currently no drug that treats sleep apnea. However, the third clinical trial of AD109 suggests there could be one in the future. Taylor Leamey wrote about all things wellness for CNET, ...

An existing drug has shown it can significantly improve the quality of sleep for those suffering from obstructive sleep apnea (OSA), so much so that many trial participants were able to hang up their ...

Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study. Jessica was a writer on the Wellness team, with a focus on health technology, ...

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight loss drug Zepbound and ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

A new drug could put an end to cumbersome CPAP machines, which are thought to be used by some 33 million Americans to manage their sleep apnea. Roughly 39 million Americans, including President Biden, ...